Phase 2 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part voluntarily, have signed a consent form, and are able to follow the study's requirements.
- People whose physical functioning is rated as 0 or 1 on a standard oncology scale (meaning they are fully active or have only minor limitations in physical activity).
- People whose cancer cells have tested positive for a protein called CD19, confirmed through laboratory testing of blood or tissue samples.
Who may not be able to join:
- People who have a primary immune deficiency (a condition where the immune system does not work properly from birth or early in life).
- People who have had a serious blood clot in a deep vein or in the lungs within the past 6 months that required blood-thinning medication.
- People who have any other medical condition that could affect how safely or accurately the trial team can assess the treatment's safety or effectiveness (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613602100955
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence and severity of adverse events per CTCAE 5.0
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.